ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1301

Characterizing How SLE Patients Access Health Information Pre and During COVID-19

Francesca Cardwell1, Susan Elliott2, May Choi3, Ricky Chin4 and Ann Clarke5, 1University of Waterloo, Burlington, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5University of Calgary, Calgary, Canada

Meeting: ACR Convergence 2020

Keywords: Access to care, COVID-19, health behaviors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The spread of misinformation related to COVID-19 has been especially acute for SLE patients as unsubstantiated claims regarding the efficacy of antimalarials for COVID-19 first jeopardized drug supplies, and then misinformation regarding toxicity provoked abrupt discontinuation. Conflicting health messages based on unfounded information can contribute to detrimental health decisions, exacerbate stress, and precipitate SLE flares. In attempt to mitigate the adverse consequences of accessing, spreading, and acting on misinformation, we assessed how SLE patients access health information pre and during COVID-19.

Methods: SLE patients fulfilling the ACR or Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria for SLE from a patient cohort in Alberta, Canada completed an online survey in June 2020 regarding the sources of health information they accessed in the 12 months preceding (pre March 11, 2020) and during the COVID-19 (post March 11, 2020) pandemic. Descriptive statistics were used to calculate the percentage of patients accessing each source of information, their preferred sources, and the level of trust in each source. McNemar tests were used to compare frequencies preceding and during the pandemic.

Results: 106 of 248 patients completed the survey (43% response rate); 91.5% were female, 71.7% Caucasian, and the mean age at diagnosis was 35.9 years (SD 14.0) and mean disease duration was 16.6 years (SD 12.8). 73.6% had completed some form of post-secondary education, and 83% reported taking antimalarials in the past 12 months. No participants reported a doctor diagnosis of COVID-19. Patients accessed news media more frequently during the pandemic (38.7% accessed sometimes/often/always pre vs 56.6% post), while access to family physicians, SLE specialists, pharmacists and alternative care providers decreased during the pandemic (Table 1). Lupus specialists and family physicians were ranked the most preferred (Table 2) and considered the most trustworthy sources (Table 3) pre and during the pandemic. News and social media were ranked more highly as preferred sources post vs pre March 11 (Table 2), but were considered much less trustworthy than physicians (86.8% rated lupus specialists as somewhat/very trustworthy post vs 38.7% for online news media).

Conclusion: Although SLE specialists and family physicians are ranked as the most preferred and trustworthy sources of health information, patients accessed these sources less frequently during the pandemic and accessed news media, a less preferred source, more frequently. This study is currently being expanded to include additional Canadian and international centers to further investigate the sociodemographic and geographic factors influencing access to and use of health information. This research will improve existing information dissemination pathways valued by SLE patients and enhance public health response during the pandemic and beyond.


Disclosure: F. Cardwell, None; S. Elliott, None; M. Choi, None; R. Chin, None; A. Clarke, AstraZenca, 5, Exagen Diagnostics, 5.

To cite this abstract in AMA style:

Cardwell F, Elliott S, Choi M, Chin R, Clarke A. Characterizing How SLE Patients Access Health Information Pre and During COVID-19 [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/characterizing-how-sle-patients-access-health-information-pre-and-during-covid-19/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterizing-how-sle-patients-access-health-information-pre-and-during-covid-19/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology